Global $38.79 Bn Companion Diagnostic Markets to 2026 with Focus on Kits and Reagents, Assays, Software, and Services – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Companion Diagnostic Market, By Products and Services (Kits and Reagents, Assays, Software, and Services), By Technology, By Disease Indication, By End-User, By Application, By Region, Competition Forecast & Opportunities, 2026” report has been added to ResearchAndMarkets.com’s offering.
The Global Companion Diagnostic Market is expected to reach USD38.79 billion by 2026, growing at double-digit CAGR of 11.13%.
The key factor responsible for the growth of companion diagnostic market is the growing cases of cancer across the globe. Additionally, increase in requirement for targeted therapy is another major factor which is anticipated to bode well for the growth of companion diagnostic market in the coming years. Moreover, rising number of clinical trials is further anticipated to bolster the market growth until 2026.